Evolent Health, Inc. (EVH) Net margin 2016–2025
Evolent Health, Inc. (EVH) net profit margin by fiscal year — reported net income divided by reported revenue.
-30.9%FY2025 · since FY2016: -62.8% → -30.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -30.9% | -27.2 pp |
| FY2024 | -3.7% | +3.6 pp |
| FY2023 | -7.2% | -5.8 pp |
| FY2022 | -1.4% | +2.7 pp |
| FY2021 | -4.1% | +32.0 pp |
| FY2020 | -36.1% | -0.5 pp |
| FY2019 | -35.7% | -27.3 pp |
| FY2018 | -8.4% | +5.6 pp |
| FY2017 | -13.9% | +48.9 pp |
| FY2016 | -62.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice